Integrated Parkinson Care Networks: Assessment of Economics and Socials Barriers
ECOSO-ICAREPD
1 other identifier
observational
72
1 country
1
Brief Summary
According to the latest public health report in France, Parkinson's disease (PD) affects around 160,000 patients. It is therefore essential to estimate the overall consumption of medical and non-medical resources by patients with PD in order to characterize the share of medical and non-medical care reimbursed by health insurance, the share of medical and non-medical care not reimbursed. by health insurance, as well as the share of formal and informal care in order to identify potential economic barriers to an optimal care path for patients with PD. It is also necessary to have information on the socio-economic characteristics and the place of residence of the resident in order to estimate the impact of these determinants on an optimal course of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2020
CompletedFirst Posted
Study publicly available on registry
July 24, 2020
CompletedStudy Start
First participant enrolled
February 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 2, 2021
CompletedJune 22, 2023
June 1, 2023
5 months
July 21, 2020
June 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identify the economic barriers to an optimal care path
It is the collection of the number of resources consumed and the remainder to be borne by the patient as well as the number of hours of informal help that will be valued using the replacement cost approach.
Day 0
Secondary Outcomes (2)
Identify and quantify the cost of the care pathway for patients with Parkinson's disease
Day 0
identify socio-economic determinants
Day 0
Study Arms (1)
Parkinson's disease patients
Parkinson's disease patients and over 18 years old
Interventions
The patient answers the questionnaire directly following his consultation or teleconsultation or may arrange a telephone appointment with the clinical research associate a little later.
Eligibility Criteria
Parkinson's disease patients and over 18 years old
You may qualify if:
- Patients with Parkinson's disease of any stage of severity
- Patients over 18 years of age
- Patients living at home
- Patient consultant at the expert center Parkinson's at Toulouse University Hospital
You may not qualify if:
- Pregnant and lactating woman
- Patient under guardianship, curatorship or safeguard of justice
- Person who does not understand French to be able to answer the questionnaire
- Patient who participated or participated in the iCare PD project
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Toulouse
Toulouse, 31059, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier Rascol
University Hospital, Toulouse
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2020
First Posted
July 24, 2020
Study Start
February 12, 2021
Primary Completion
July 2, 2021
Study Completion
July 2, 2021
Last Updated
June 22, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share